134 related articles for article (PubMed ID: 15171187)
1. Screening postmortem whole blood for oxycodone by ELISA response ratios.
Spiehler VR; DeCicco L; McCutcheon JR; Kupiec T; Kemp P
J Forensic Sci; 2004 May; 49(3):621-6. PubMed ID: 15171187
[TBL] [Abstract][Full Text] [Related]
2. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
[TBL] [Abstract][Full Text] [Related]
3. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
Lachenmeier K; Musshoff F; Madea B
Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
[TBL] [Abstract][Full Text] [Related]
4. Validation of a microtiter plate ELISA for screening of postmortem blood for opiates and benzodiazepines.
Kemp P; Sneed G; Kupiec T; Spiehler V
J Anal Toxicol; 2002 Oct; 26(7):504-12. PubMed ID: 12423008
[TBL] [Abstract][Full Text] [Related]
5. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the DRI oxycodone immunoassay for the detection of oxycodone in urine.
Backer RC; Monforte JR; Poklis A
J Anal Toxicol; 2005 Oct; 29(7):675-7. PubMed ID: 16419399
[TBL] [Abstract][Full Text] [Related]
7. Setting cutoff concentrations for immunoassay screening of postmortem blood.
Collison IB; Spiehler VR; Guluzian S; Sedgwick PR
J Forensic Sci; 1998 Mar; 43(2):390-4. PubMed ID: 9544549
[TBL] [Abstract][Full Text] [Related]
8. Performance of a microtiter plate ELISA for screening of postmortem blood for cocaine and metabolites.
Spiehler V; Isenschmid DS; Matthews P; Kemp P; Kupiec T
J Anal Toxicol; 2003; 27(8):587-91. PubMed ID: 14670138
[TBL] [Abstract][Full Text] [Related]
9. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
Smith ML; Hughes RO; Levine B; Dickerson S; Darwin WD; Cone EJ
J Anal Toxicol; 1995; 19(1):18-26. PubMed ID: 7536861
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens.
Cirimele V; Etienne S; Villain M; Ludes B; Kintz P
Forensic Sci Int; 2004 Jul; 143(2-3):153-6. PubMed ID: 15240036
[TBL] [Abstract][Full Text] [Related]
11. Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine.
Kupiec T; DeCicco L; Spiehler V; Sneed G; Kemp P
J Anal Toxicol; 2002 Oct; 26(7):513-8. PubMed ID: 12423009
[TBL] [Abstract][Full Text] [Related]
12. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine.
Gingras M; Laberge MH; Lefebvre M
J Anal Toxicol; 2010 Mar; 34(2):78-83. PubMed ID: 20223099
[TBL] [Abstract][Full Text] [Related]
14. Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.
Heltsley R; Zichterman A; Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
J Anal Toxicol; 2010; 34(1):32-8. PubMed ID: 20109300
[TBL] [Abstract][Full Text] [Related]
15. Improved oxymorphone detection in postmortem specimens.
Moore C; Vincent M
J Anal Toxicol; 2010 Mar; 34(2):112. PubMed ID: 20223105
[No Abstract] [Full Text] [Related]
16. Considerations in the interpretation of urine analyses in suspected opiate intoxications.
Levine B; Smialek JE
J Forensic Sci; 1998 Mar; 43(2):388-9. PubMed ID: 9544548
[TBL] [Abstract][Full Text] [Related]
17. Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
Neuvonen M; Neuvonen PJ
Ther Drug Monit; 2008 Jun; 30(3):333-40. PubMed ID: 18520605
[TBL] [Abstract][Full Text] [Related]
18. GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood.
Meatherall R
J Anal Toxicol; 2005; 29(5):301-8. PubMed ID: 16105253
[TBL] [Abstract][Full Text] [Related]
19. Desomorphine Screening Using Commercial Enzyme-Linked Immunosorbent Assays.
Winborn J; Kerrigan S
J Anal Toxicol; 2017 Jun; 41(5):455-460. PubMed ID: 28369523
[TBL] [Abstract][Full Text] [Related]
20. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory.
Haller CA; Stone J; Burke V; Branch J; Chen K; Gross S
J Anal Toxicol; 2006 Mar; 30(2):106-11. PubMed ID: 16620541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
